bioRxivCancer BiologyPreprint
Interactions between ploidy and resource availability shape clonal interference at initiation and recurrence of glioblastoma
Z. Nowicka, F. Rentzeperis, R. Beck, V. Tagal, A. M. Forero Pinto, E. Scanu, T. Veith, J. Cole, D. Ilter, W. Dominguez Viqueira, J. K. Teer, K. Maksin, S. Pasetto, M. A. Abdalah, G. Fiandaca, S. Prabhakaran, A. Schultz, M. Ojwang, J. S. Barnholtz-Sloan, F. M. Joaquim, A. P. Gomes, P. Katira, N. Andor
Abstract
Glioblastoma (GBM) is the most aggressive form of primary brain tumor. Complete surgical resection of GBM is almost impossible due to the infiltrative nature of the cancer. While no evidence for recent selection events have been found after diagnosis, the selective forces that govern gliomagenesis are strong, shaping the tumors cell composition during the initial progression to malignancy with late consequences for invasiveness and therapy response. We present a mathematical model that simulates the growth and invasion of a glioma, given its ploidy level and the nature of its brain tissue micro-environment (TME), and use it to make inferences about GBM initiation and response to standard-of-care treatment. We approximate the spatial distribution of resource access in the TME through integration of in-silico modelling, multi-omics data and image analysis of primary and recurrent GBM. In the pre-malignant setting, our in-silico results suggest that low ploidy cancer cells are more resistant to starvation-induced cell death. In the malignant setting, between first and second surgery, simulated tumors with different ploidy compositions progressed at different rates. Whether higher ploidy predicted fast recurrence, however, depended on the TME. Historical data supports this dependence on TME resources, as shown by a significant correlation between the median glucose uptake rates in human tissues and the median ploidy of cancer types that arise in the respective tissues (Spearman r = -0.70; P = 0.026). Taken together our findings suggest that availability of metabolic substrates in the TME drives different cell fate decisions for cancer cells with different ploidy and shapes GBM disease initiation and relapse characteristics.
- organism: human
- assay: multiome
- research focus: cell signaling & trafficking
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- From cells to tissue: How cell scale heterogeneity impacts glioblastoma growth and treatment response
J. A. Gallaher, S. C. Massey, … A. R. A. Anderson·bioRxiv·May 26, 2019
- Subclonal evolution and expansion of THY1-positive cells is associated with recurrence in glioblastoma
W. N. Al-Holou, H. Wang, … A. Rehemtulla·bioRxiv·Sep 10, 2021
- Lets Get Physical: On Observing Force Perturbations of Proliferating Glioblastoma-related Astrocyte Cells
- Glioblastoma cell fate is differentially regulated by the microenvironments of the tumour bulk and infiltrative margin
C. Garcia-Diaz, E. Mereu, … S. Parrinello·bioRxiv·Jun 11, 2021
- Gibbs Process Determines Survival and Reveals Contact-Inhibition Genes in Glioblastoma Multiforme
L. Kannan, T. Agarwal, … K. Kannan·bioRxiv·Apr 17, 2019
- Coevolution of neoplastic and non-neoplastic reactive astrocyte states converges on mesenchymal-like and injury-response programs during murine glioblastoma progression and post-radiotherapy recurrence
David Lindgren, Rebecca Rosberg, … Alexander Pietras·bioRxiv·Dec 22, 2025